Related Experiment Video
Updated: Apr 17, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Brief Behavioral Interventions for Symptoms of Depression and Insomnia in University Primary Care
Objective:
To describe how behavioral activation (BA) for depression and stimulus control (SC) for insomnia can be modified to a brief format for use in a university primary care setting, and to evaluate preliminarily their effectiveness in reducing symptoms of depression and insomnia, respectively, using data collected in routine clinical care.
Participants/Methods:
Chart review data were obtained for 11 patients treated between August 2009 and December 2010 with 1 session of brief BA for depression and 17 patients treated with 1 session of brief SC for insomnia.
Results:
At 2-week follow-up, patients reported significant decreases in symptoms of depression on the Patient Health Questionnaire-9, t(10) = 3.95, p < .05, and insomnia on the Insomnia Severity Index, t(16) = 5.43, p < .05, respectively.
Conclusions:
This case report provides preliminary evidence of the external validity of brief BA and SC after they were adapted for use within university primary care.
More Related Videos
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antidepressant Drugs: MAOIs and Other Agents
CNS Depressants: Barbiturates and Benzodiazepines

